Insulet Corp

Common Name

Insulet

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

3,900

Ticker

PODD

Exchange

NASDAQ/NGS

Website

www.omnipod.com

Description

Insulet Corporation is a prominent healthcare company specializing in medical devices, with a key focus on diabetes management. Its flagship product, the Omnipod Insulin Management System, is an innov... Show more

Financial Statements of Insulet

Below are the financial statements of Insulet, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	953.4^a	704.2^a
Accounts receivable trade, net	252.5^a	240.2^a
Accounts receivable trade, net - related party	113^a	119.5^a
Inventories	430.4^a	402.6^a
Prepaid expenses and other current assets	142^a	116.4^a
Total current assets	1,891.3^a	1,582.9^a
Assets	—	—
Property, plant and equipment, net	723.1^a	664.9^a
Other intangible assets, net	98.5^a	98.7^a
Goodwill	51.5^a	51.7^a
Deferred tax assets	141.8^a	1.8^a
Other assets	181.5^a	188.2^a
Total assets	3,087.7^a	2,588.2^a
Current liabilities	—	—
Accounts payable	19.8^a	19.2^a
Accrued expenses and other current liabilities	423.8^a	373.7^a
Accrued expenses and other current liabilities - related party	1^a	8.9^a
Current portion of long-term debt	83.8^a	49.4^a
Total current liabilities	528.4^a	451.2^a
Liabilities and stockholders’ equity	—	—
Long-term debt, net	1,296.1^a	1,366.4^a
Other liabilities	51.6^a	37.9^a
Total liabilities	1,876.1^a	1,855.5^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0.1^a	0.1^a
Additional paid-in capital	1,184.4^a	1,102.6^a
Accumulated earnings (deficit)	40.3^a	-378^a
Accumulated other comprehensive (loss) income	-13.2^a	8^a
Total stockholders’ equity	1,211.6^a	732.7^a
Total liabilities and stockholders’ equity	3,087.7^a	2,588.2^a

Verified Sources Behind Insulet’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Insulet’s data sources below and access millions more through our Disclosure Search.

a. Insulet's 10-K 2024

Trace every data point back to Insulet’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Insulet Corp

Financial Statements of Insulet

Verified Sources Behind Insulet’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Dexcom Inc

Globus Medical Inc

Bio Rad Laboratories Inc

Stryker Corp

Procept Biorobotics Corp

Masimo Corp